mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |